BIONET Statistics
Total Valuation
BIONET has a market cap or net worth of TWD 4.34 billion. The enterprise value is 3.92 billion.
Market Cap | 4.34B |
Enterprise Value | 3.92B |
Important Dates
The last earnings date was Friday, March 28, 2025.
Earnings Date | Mar 28, 2025 |
Ex-Dividend Date | Sep 19, 2024 |
Share Statistics
BIONET has 50.83 million shares outstanding. The number of shares has increased by 0.33% in one year.
Current Share Class | n/a |
Shares Outstanding | 50.83M |
Shares Change (YoY) | +0.33% |
Shares Change (QoQ) | +0.52% |
Owned by Insiders (%) | 9.39% |
Owned by Institutions (%) | 0.27% |
Float | 40.26M |
Valuation Ratios
The trailing PE ratio is 51.76.
PE Ratio | 51.76 |
Forward PE | n/a |
PS Ratio | 3.54 |
PB Ratio | 3.25 |
P/TBV Ratio | 3.32 |
P/FCF Ratio | 57.76 |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 38.92, with an EV/FCF ratio of 52.19.
EV / Earnings | 46.85 |
EV / Sales | 3.21 |
EV / EBITDA | 38.92 |
EV / EBIT | 62.85 |
EV / FCF | 52.19 |
Financial Position
The company has a current ratio of 5.06, with a Debt / Equity ratio of 0.04.
Current Ratio | 5.06 |
Quick Ratio | 4.77 |
Debt / Equity | 0.04 |
Debt / EBITDA | 0.94 |
Debt / FCF | 1.25 |
Interest Coverage | 48.78 |
Financial Efficiency
Return on equity (ROE) is 3.39% and return on invested capital (ROIC) is 1.83%.
Return on Equity (ROE) | 3.39% |
Return on Assets (ROA) | 1.42% |
Return on Invested Capital (ROIC) | 1.83% |
Return on Capital Employed (ROCE) | 2.26% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.44 |
Inventory Turnover | 7.84 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +45.16% in the last 52 weeks. The beta is 0.59, so BIONET's price volatility has been lower than the market average.
Beta (5Y) | 0.59 |
52-Week Price Change | +45.16% |
50-Day Moving Average | 83.56 |
200-Day Moving Average | 95.02 |
Relative Strength Index (RSI) | 52.52 |
Average Volume (20 Days) | 319,181 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BIONET had revenue of TWD 1.22 billion and earned 83.70 million in profits. Earnings per share was 1.65.
Revenue | 1.22B |
Gross Profit | 685.77M |
Operating Income | 62.40M |
Pretax Income | 102.24M |
Net Income | 83.70M |
EBITDA | 89.71M |
EBIT | 62.40M |
Earnings Per Share (EPS) | 1.65 |
Balance Sheet
The company has 1.57 billion in cash and 94.28 million in debt, giving a net cash position of 1.48 billion or 29.12 per share.
Cash & Cash Equivalents | 1.57B |
Total Debt | 94.28M |
Net Cash | 1.48B |
Net Cash Per Share | 29.12 |
Equity (Book Value) | 2.40B |
Book Value Per Share | 26.26 |
Working Capital | 1.60B |
Cash Flow
In the last 12 months, operating cash flow was 176.49 million and capital expenditures -101.35 million, giving a free cash flow of 75.15 million.
Operating Cash Flow | 176.49M |
Capital Expenditures | -101.35M |
Free Cash Flow | 75.15M |
FCF Per Share | 1.48 |
Margins
Gross margin is 56.12%, with operating and profit margins of 5.11% and 6.85%.
Gross Margin | 56.12% |
Operating Margin | 5.11% |
Pretax Margin | 8.37% |
Profit Margin | 6.85% |
EBITDA Margin | 7.34% |
EBIT Margin | 5.11% |
FCF Margin | 6.15% |
Dividends & Yields
This stock pays an annual dividend of 1.41, which amounts to a dividend yield of 1.65%.
Dividend Per Share | 1.41 |
Dividend Yield | 1.65% |
Dividend Growth (YoY) | 9.05% |
Years of Dividend Growth | 4 |
Payout Ratio | 39.61% |
Buyback Yield | -0.33% |
Shareholder Yield | 1.32% |
Earnings Yield | 1.93% |
FCF Yield | 1.73% |
Stock Splits
The last stock split was on September 19, 2024. It was a forward split with a ratio of 1.070923771.
Last Split Date | Sep 19, 2024 |
Split Type | Forward |
Split Ratio | 1.070923771 |
Scores
BIONET has an Altman Z-Score of 4.44.
Altman Z-Score | 4.44 |
Piotroski F-Score | n/a |